Skip to content

The National Lipedema Study

Surgical Treatment of Lipedema in Norway - a National Multicenter Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05284266
Enrollment
220
Registered
2022-03-17
Start date
2022-03-11
Completion date
2027-12-31
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipedema

Keywords

Liposuction, Conservative treatment, Intermittent pneumatic compression, Lipoedema, Compression therapy, Self management, Dietary management

Brief summary

Lipedema is a chronic condition with a symmetrical accumulation of painful fatty tissue primarily affecting the limbs, sparing hands, feet and trunk. The subcutaneous fatty tissue is disproportionately voluminous and may have a different microstructure and metabolism than the patient's regular fatty tissue. The condition affects almost exclusively women and usually debuts around puberty. Lipedema seems to have a hereditary component, may be affected by hormonal variations and worsens with obesity. Guidelines advocate conservative treatment with compression therapy, weight management, physical activity, life style changes and psychological support;and in some cases surgical treatment such as bariatric surgery and liposuction. Treatment of lipedema is indicated when the condition causes significant pain and inhibits the patient's everyday activities. Well-designed randomized controlled studies on lipedema are lacking. The Ministry of Health and Care Services in Norway has found the scientific documentation for the effects of liposuction to be insufficient and has recommended that surgical treatment of lipedema should be evaluated through a 5-year clinical trial. A national task force, consisting of representatives from all four regional health authorities in Norway has been set up. This task force has now initiated this study. A national multi-center study with homogenous treatment protocols can provide globally sought insight on lipedema and the effect of its treatment regimes, and the findings will be important to adjust future treatment strategies regarding both effect and cost/effectiveness.

Interventions

Standard Conservative treatment consisiting of: Physical therapy, including compression garment and exercise program, Self-care program

PROCEDURELiposuction early

Liposuction 6-9 months after inclusion

PROCEDURELiposuction late

Liposuction 18-21 months after inclusion

OTHERStandard conservative treatment with Intermittent Pneumatic Compression (IPC)

Physical therapy, including compression garment and exercise program, Self-care program and Intermittent Pneumatic Compression (IPC)

Sponsors

St. Olavs Hospital
CollaboratorOTHER
University Hospital of North Norway
CollaboratorOTHER
Sykehuset Telemark
CollaboratorOTHER_GOV
University of Bergen
CollaboratorOTHER
Klinbeforsk
CollaboratorOTHER
Helse Vest
CollaboratorOTHER
Haraldsplass Deaconess Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Eligible patients are randomized to two different conservative treatment protocols;either standard conservative treatment (SCT) or standard treatment plus additional lymphedema treatment (intermittent pneumatic compression -IPC). After 6 months the effects of the conservative treatment are evaluated. Patients who still want surgery and fulfill the criteria are randomized (1:1) to early (cases(liposuction initiated 6-9 months after inclusion)) or late surgery (controls (liposuction initiated 18-21 months after inclusion)). Randomization to the surgical group is stratified by conservative treatment arm.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* female * age 20-65 years * significant pain from lipedema * lipedema stage 1-2 or localized stage 3

Exclusion criteria

* Non-fluency in the Norwegian language * pregnancy * current malignancy * previous surgical treatment for lipedema * smoking * BMI \> 28 * serious comorbidities such as cardiac-, pulmonary-, renal disease * unwillingness to wear compression garments

Design outcomes

Primary

MeasureTime frameDescription
Effect of liposuction on lipedema pain12 months after the last liposuction surgeryAssess the effect of liposuction on lipedema pain (Visual Analog Scale (VAS). VAS consists of a 10 cm line, with two end points representing 0 (no pain) and 10 (worst possible pain).

Secondary

MeasureTime frameDescription
Effect of liposuction on quality of life and everyday activities for patients with lipedema12 months after the last liposuction surgeryAssess the effect of liposuction on quality of life and everyday activities (RAND-36)

Other

MeasureTime frameDescription
Effect of different conservative treatments on lipedema pain and quality of life and everyday activities for patients with lipedema6 months after inclusionEffect of two different conservative treatments strategies on pain and everyday activities (RAND-36)
Adverse effect of liposuction12 months after last liposuction surgeryAssess possible adverse effects of liposuction
Effect of liposuction on the need for conservative treatment3 years after last liposuction surgeryAssess whether having undergone liposuction changes the need for conservative treatment.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026